Stephen R. Brady's most recent trade in Tempest Therapeutics Inc was a trade of 550,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tempest Therapeutics Inc | Stephen R. Brady | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 550,000 | 550,000 | - | - | Employee Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Stephen R. Brady | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 03 Jul 2024 | 35,000 | 46,376 | - | 2.1 | 73,850 | Common Stock |
| Tempest Therapeutics Inc | Brady Stephen R. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| Atreca Inc - Ordinary Shar... | Stephen R. Brady | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Stephen R. Brady | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 177,300 | 177,300 | - | - | Employee Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Stephen R. Brady | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 173,533 | 173,533 | - | - | Stock Option (Right to Buy) | |
| Atreca Inc - Ordinary Shar... | Stephen R. Brady | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Stephen R. Brady | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 94,500 | 94,500 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Stephen R. Brady | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 1,982,250 | 1,982,250 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Stephen R. Brady | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 110,432 | 110,432 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Stephen R. Brady | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 70,256 | 70,256 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Stephen R. Brady | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 8,050 | 8,050 | - | - | Stock Option (Right to Buy) |